The present application describes methods for treating cancer with anti-ErbB2 antibodies, such as humanized anti-ErbB2 antibodies, and EGFR-targeted drugs.

 
Web www.patentalert.com

< Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists

> Selective androgen receptor modulators and method of use thereof

> Stable aqueous formulation of a soluble TNF receptor and arginine
~ 00560